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The beneficial effects in humans of ingesting fish oils have attracted much attention among
medical scientists and nutritionists recently. Human studiesconducted in populations ofEskimos,
Japanese, and Caucasians since 1970 are reviewed in this paper. The evidence shows that a diet
rich in omega-3 fatty acids significantly reduces plasma cholesterol and triglyceride levels,
improves fat tolerance, prolongs bleeding times, reduces platelet counts, and decreases platelet
adhesiveness.
INTRODUCTION
Three research studies on the beneficial effects of fish oil on human health, which
were published in a single issue of the New England Journal of Medicine in 1985
[1,2,3] attracted much attention to the nutritional properties of fish oils. Glomset [4]
observed in an editorial in this particular issue that these studies (a) emphasize the fact
that different types of polyunsaturated fatty acids can have vastly different metabolic
effects and (b) raise questions in particular about the relation of omega-3 polyunsatu-
rated fatty acids to human development, growth, and disease. In addition, a triglycer-
ide-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia
[5] and studies on feeding fish oil concentrate to stroke patients [6] were also reported.
In view of these findings, a review of recent literature on the human studies of the
beneficial effects ofingesting fish oils seems pertinent.
An excellent, extensive review by Stansby [7] covers wide areas such as chemistry,
sources, and nutritional properties of fish oils. Ackman [8,9] surveyed in depth the
literature published since 1950 on fish lipids and fatty acid composition of fish oils.
Studies on auto-oxidation and measurement ofoxidation have been reviewed by Hardy
[10]. Biological information on the long-chain mono-enoic fatty acids in partially
hydrogenated oils has been compiled in the symposium proceedings edited by Barlow
and Stansby [11].
In this review, studies reported since 1970 on the effects offish oils on human health
are considered. For literature published in the pre-1970 period, the reader should refer
to the earlier reviews [7,12,13,14,15].
FATTY ACID COMPOSITION
Herring, menhaden, pilchard, sardine, and whale are the major sources of fish oils.
Although whales are marine mammals, because of their ecological, functional, and
physiological similarities to fish, whale oil is included in the categoryoffish oils. In this
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review, only the dietary effects of fish oils are considered, and oils from aquatic
invertebrates such as shrimp, crabs, oysters, and small crustaceans are not included.
According to the compilations of Weiss [16], iodine values reported for herring,
menhaden, pilchard, and sardine range from 148 to 200. The whale oil has an iodine
value range from 110 to 135. (Iodine value is a measure of unsaturation of oil and is
defined as the percentage of iodine that will be absorbed by a chemically unsaturated
substance in a given time.) The predominant polyunsaturated fatty acids in the oils of
herring and menhaden are eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA). Pilchard, sardine, and whale oils are rich in arachidonic acid (AA). The
classic monograph on the chemical composition of natural fats by Hilditch and
Williams [17] provides an exhaustive listing of the fatty acid components of marine
elasmobranch fish (liver fats), marine teleost fish (liver fats and body fats), freshwater
fish, salmon, eel, sturgeon, tuna, grouper, and the whale family.
One ofthe most prominent specific component acids offish oils in hexadecenoic acid
C16H3002. Polyenoic acids of the C18, C20, C22, C24, and even, perhaps, C26 series
contribute to the ready auto-oxidation offish oils. Ofthese, the C20 and C22 groups of
polyunsaturated fatty acids are most abundant in fish. The degree of unsaturation
among fatty acids is an indication ofthe number ofdouble bonds in the molecule. The
larger the number ofdouble bonds, the higher thedegree ofunsaturation present in the
polyenoic acid. The location ofthe double bond in the molecule is denoted by counting
from the methyl (omega) terminus. Omega-6 and omega-3 families of dietary
unsaturated fatty acids are ofclinical interest. In the omega-3 family, the first double
bond is located on the third carbon atom from the methyl end; the omega-6 family has
the first double bond located on the sixth carbon atom from the methyl end.
Arachidonic acid (C20:4) belongs to the omega-6 family; eicosapentaenoic acid
(C20:5) and docosahexaenoic acid (C22:6) belong to the omega-3 family.
Cod liver oil is the most widely used of the fish liver oils, as a consequence of its
medicinal value. Hilditch and Williams [17] reported that on a percentage weight
basis, the cod liver oil is rich in EPA (9.3 percent), DHA (8.7 percent), and AA (2.2
percent). Though in the U.S.A. fish oils are not used for edible purposes, they are used
extensively in Canada and Europe for the manufacture of shortenings and margarine
[16]. Other ethnic populations such as Eskimos and Japanese consume large quantities
of oils of marine origin, due to their accessibility and the social evolution of seafood
eating habits.
STUDIES ON THE ESKIMO POPULATION
A series of prospective studies on Greenland Eskimos conducted by Dyerberg's
group [18,19,20,21,22,23,24,25,26,27,28] revealed that the rarity of ischemic heart
disease and the decreased thrombous tendency in this population could be linked to the
ingestion of omega-3 fatty acids, derived largely from whale, seal, and fish. Dyerberg
[29] and Dyerberg and Jorgensen [30] reviewed their studies on the influence of
marine oils on lipoprotein metabolism in Greenland Eskimos. A coherent picture has
emerged, pointing to fish oils as a major factor responsible for the low incidence of
thrombotic disorders in Eskimos. Some salient facts are:
1. Eskimos eat more mono- and polyunsaturated fat at the expense of saturated
fat. In addition, the polyunsaturated fats belong mainly to the marine omega-3
class. On a caloric intake of 3,000 kcal/day, 4.6 percent of C20:5 omega-3
fatty acid corresponds to an intake of 5.7 g EPA per day [20,26].
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2. Eskimos have lower plasma triglyceride and cholesterol levels (in comparison
to the Danish population) due to lower LDL and VLDL concentrations.
Expatriate Eskimos living in Denmark did not differ in their plasma lipid and
lipoprotein levels from Caucasian Danes. Thus, it could be inferred that the
findings were not necessarily ofgenetic origin but were due to the influence of
exogenous factors, presumably dietary [18,21].
3. The ratio of EPA to AA (by percentage weight in blood plasma), the
precursors for prostaglandin synthesis, ranged for Eskimos from 1.5 to 2.7 in
the three lipid groups, triglycerides, phospholipids, and cholesterol esters,
compared to 0.2-0.5 for Danes [19,25].
4. Eskimos had bleeding times significantly longer than those of Danes, but the
bleeding times of expatriate Greenlanders living in Denmark did not differ
from those of other Danes. It was also demonstrated that the prolongation of
bleeding time was due to a decreased platelet aggregability, accompanied by a
shift in platelet fatty acid composition from the omega-6 to theomega-3 family
[24].
5. Immunoreactive anti-thrombin-Ill (AT-Ill) or heparin co-factor in blood
serum was found to be significantly higher in Greenland Eskimos than in
expatriate Eskimos, who themselves had significantly higher levels than
Danish controls.
However, Dyerberg [29] also cautioned about the pitfalls of obtaining medical
statistical data from a society such as that in Greenland, which changes quickly as the
original pattern of life style vanishes. This constantly changing social fabric and life
style of the Eskimos could in turn eliminate the very factors which are actively
investigated by the researchers.
STUDIES ON THE CAUCASIAN POPULATION
Following the trend-setting contributions by Dyerberg's group, human volunteer
feeding experiments have been conducted by researchers from other countries as well
[31,32,33,34,35,36,37,38,39,40,41,42]. Efforts were made to show that a supplemen-
tation of omega-3 fish polyunsaturated fatty acids to the Western-style diet could
result in a depression ofplatelet aggregability accompanied by an increase in omega-3
polyunsaturated fatty acids in the platelet lipids.
To find out whether salmon oil feeding would result in the uptake ofomega-3 fatty
acids into platelets and whether platelet function would be inhibited or bleeding times
prolonged, Goodnight et al. [35] conducted a prospective, controlled trial. Six maleand
five female volunteers were feddiets containing salmon oil and salmon. It was observed
that diets containing salmon oil led to the incorporation of EPA in the phospholipid
fraction offatty acids in platelets (6.1 percent by weight) with a reduction in AA. The
ratioofEPA to AA increased from 0.0045 on the control diet to 0.3 on the salmon diet.
Bleeding times were prolonged from 6.75 to 10 minutes, and platelet retention on glass
beads was mildly reduced from 89 percent to 78 percent. Goodnight et al. [35]
concluded that in normal subjectsdietary omega-3 fattyacids derived from salmon oils
were incorporated into platelet phospholipids and that these changes were accompa-
nied by alterations in bleeding time and platelet function.
Thorngren and Gustafson [34] also studied the effect of a diet rich in EPA on
platelet phospholipid fatty acid composition, platelet aggregation, and bleeding time in
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ten healthy Swedish students. The diet ofthevolunteers was partly replaced by fish for
eleven weeks, and this diet provided 2-3 g of EPA per day. The fish diet prolonged
bleeding time by 42 percent and decreased platelet aggregability. The changes in
platelet phospholipid fatty acid composition consisted of increases in the omega-3
series (C20:5 and C22:6) and decreases in the omega-6 series (C18:2 and C20:3). The
authors inferred that a diet rich in omega-3 polyunsaturated fatty acids reduces the
interaction between platelets and the vessel wall by mechanisms which are more
complex than just a reduction in susceptibility of platelets to the naturally occurring
agents collagen and ADP, or an imbalance between pro-aggregatory and anti-
aggregatory prostaglandin derivatives.
Harris et al. [36] reported a metabolic study designed to determine the effects of a
diet rich in omega-3 fatty acids from salmon oil upon the plasma lipids and lipoprotein
in twelve normal subjects (mean age 40 ± 13.3 years) undercontrolled conditions. This
diet was compared to two control diets, one containing levels ofsaturated fat typical of
the American diet and the other rich in omega-6 polyunsaturated linoleic acid. The
three diets, which differed only in fatty acid composition, were fed in random order for
four weeks each. It was observed that although both of the polyunsaturated fat diets
reduced the plasma cholesterol levels, only the salmon oil diet caused a significant
decrease in triglyceride levels. Harris et al. [36] inferred that fattyacids present in fish
oils are potentially useful in the control ofboth hypertriglyceridemia and hypercholes-
terolemia.
Subsequently, Harris et al. [37] also studied the effect of dietary fish oils on the
plasma triglyceride and VLDL levels thatoccur physiologically after the induction ofa
high-carbohydrate diet. A baseline diet (45 percent fat, 10 percent protein, 45 percent
carbohydrate) and two high-carbohydrate diets (15 percent fat, 10 percent protein, 75
percent carbohydrate) were fed to seven mildly hypertriglyceridemic, but otherwise
healthy volunteers (22-54 years of age). One carbohydrate diet served as the control
and the other contained cod liver oil. The baseline and control dietary fats were a
mixture of peanut oil and cocoa butter. It was found that dietary omega-3 fatty acids
from fish oil rapidly and markedly reduced VLDL triglyceride levels even in the face of
a high-carbohydrate diet. Harris et al. [37] hypothesized that fish oil lowered plasma
triglyceride levels by inhibiting the synthesis ofVLDL triglyceride or by enhancing its
clearance in the periphery. Cartwright et al. [41] inferred that modification of blood
rheology by dietary omega-3 fatty acids is of potential value in the treatment of
vascular disease.
STUDIES ON THE JAPANESE POPULATION
Apart from the Eskimo population, the changing patterns ofischemic heart disease,
nutrient intake, and HDL cholesterol levels have been studied only among the
Japanese [43,44,45,46,47,48,49]. The Japanese life style can becategorized into three
types:
a. Farmland type, wherethe traditional lifestyledictates a dietconsisting mainly
ofrice
b. Fishing village type, where the residents eat chiefly fish
c. Urban residents with a diet pattern similar to that ofthe Western world [43]
Hirai et al. [48] compared the dietary fatty acid composition and distribution of
fatty acids in total plasma lipid of the residents of a fishing village and a farming
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village in the Chiba prefecture ofJapan. The observations revealed:
1. Those living in the fishing village consumed 250 g of fish per person per day
(equivalent to 2.5 g ofEPA) and the farming village population ingested 90 g
offish per person per day (equivalent to 0.9 g ofEPA).
2. The residents of the fishing village had a higher concentration of EPA and
DHA in their blood plasma after 12 hours of fasting than those living in the
farming village.
Another study conducted by the same research group [49] showed that the mean
blood viscosity ofthe residents in the fishing village was significantly lower than that of
those living in the farming village. These researchers [48,49] therefore inferred:
a. A seafood diet reduces blood viscosity, and EPA is mainly responsible for this
effect.
b. Since increased blood viscosity is important in the etiology of thrombotic
disorders, ingestion ofseafood rich in EPA is beneficial to health.
The daily total lipid intake among the Japanese is about one-third of that of
Americans, and the composition ofthe fatty acids in thediet and human adipose tissue
is alsoquitedifferent in the twocountries. Though theamountofpolyunsaturated fatty
acids consumed is equal in the two countries, their chemical nature is different.
Japanese consume large quantities of long-chain, highly polyunsaturated fatty acids
(AA, EPA, and DHA) supplied from fish [44]. Over the last 30 years, it has also been
deduced that the fat intake per person per day among Japanese has tripled. In 1950,
the fat intake was 18 g per capita per day, and in 1975 it had increased to 52 g per
capita per day. While, in 1950, for an average Japanese, fats constituted 7.7 percent of
the total caloric intake, this percentage had increased to 21.4 percent by 1975. Up to
1970, animal and vegetable fat intake increased in parallel, and, by 1975, animal fat
intake slightly exceeded that of vegetable fat. Although ischemic heart disease has
increased about fourfold, it is not yet as prominent as stroke [43,46]; compared with
other countries, the mortality from ischemic heart disease has remained low among
Japanese. Blood lipid concentration, one of the major risk factors for ischemic heart
disease, has also been reported as low [47].
Though the beneficial effect of consuming EPA through a high fish diet has been
confirmed in Caucasian populations in short-term feeding studies [31,32,33,36,37,39],
only among the Eskimos and Japanese do scientifically based inferences on the
long-term beneficial effect ofconsuming EPA seem possible at present. In a study on
aged persons (73.9 ± 7.8 years old) living on Kohama Island at Okinawa, Kagawa et
al. [45] found:
1. The total amount of EPA in the serum ofpersons on Kohama Island (46.77 +
7.46 mg/100 ml) was higher than that ofpeople in Japan, owing to the higher
intake offresh fish (147.7 g/day).
2. A positive correlation existed between serum EPA concentration and HDL
concentration.
3. A positive correlation existed among serum dihomo-gamma-linolenic acid
(C20:3, omega-6) concentration and total cholesterol, triglyceride, and skin
fold thickness.
4. The blood pressure level, incidence ofabnormal ECG, and salt intake (6.2-8.3
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g/day), estimated from urinalysis, were all lower than the average figures for
Japanese ofsimilar ages.
To study the effect of oral administration of EPA-rich fish oil concentrate on
platelet aggregation and the release and the metabolism of (1-'4C) arachidonic acid
and (U)-'4C EPA by human platelets, Hirai et al. [50] fed eight healthy male
volunteers 18 capsules offish oil concentrate (EPA 1.4 g) per day for four weeks. The
findings were: (1) plasma and platelet concentrations of EPA markedly increased,
while those of arachidonic acid and docosahexaenoic acid did not change; (2) platelet
aggregation induced by collagen and ADP was reduced. It was also inferred that the
release of AA from platelet lipids might be affected by the change in EPA content in
platelets. Studies reported by Kagawa et al. [45] and Hirai's group [48,49,50] revealed
that, like the Eskimo population, the Japanese population also records low rate of
thrombotic disorders, presumably due to their EPA-rich diet.
CONCLUSION
A number ofrecently published studies confirm the fact that, compared to a typical
American diet, a diet high in omega-3 fatty acids significantly reduces plasma
cholesterol and triglyceride levels, improves fat tolerance, prolongs bleeding times,
reduces platelet counts, and decreases platelet adhesiveness [2,3]. Omega-3 fatty acids
contained in fish oils appear to have two anti-atherogenic effects, a hypolipidemic
action, and an anti-thrombotic action upon the platelets [51].
Recently, Dyerberg [52] critically commented on the inference of Kromhout et al.
[1] regarding the existence of an inverse relationship between the incidence of
coronary heart disease and a relatively low level of fish intake. One should also take
note that Kromhout et al. [1] incorrectly mentioned in their paper that Eskimos
consume 400 g fish per capita per day. As has been clarified by Bang and Dyerberg
[53], on a daily basis Greenland Eskimos ingest approximately 400 g of meat from
arctic mammals (seal and whale) and not fish. At present, the precise mechanism by
which polyunsaturated omega-3 fatty acids, which are abundant in fish oils and in the
meat ofarctic mammals, exert their effects on platelet activity and VLDL biosynthesis
is unclear [54]. Future research should concentrate on long-term intervention studies
on humans to determine the cardiovascular effects ofeating fish.
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